Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2006
06/21/2006CN1260227C 5-membered ring heterocyclic compounds with nitrogen
06/21/2006CN1260225C Tetrahydropyridino or piperidino hetlrocyclic derivatives
06/20/2006USRE39140 pyridylmethylamines such as 1-(2-chloro-5-thiazolylmethyl)-2-cyanoiminoimidazolidine used as insecticides
06/20/2006US7064218 Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity
06/20/2006US7064215 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease
06/20/2006US7064214 Reacting an amino-containing sulfinic acid with a metal hydrocarbon or halometal hydrocarbon to obtain a sterically pure product; pantoprazole; omeproazole; lansproazole; rabeproazoe; gastrointestinal disorders
06/20/2006US7064213 Method for preparing 2- (2-pyridylmethylsulphinyl) benzimidazoles
06/20/2006US7064212 Dicationic viologens, such as methyl viologen and benzyl viologen, associated with anions selected from bis(trifluoro-methyl(or perfluoroethyl)sulfonyl)imide and tris(trifluoro-methylsulfonyl)methide; soluble in quat ammonium melts
06/20/2006US7064211 Hemiasterlin derivatives and uses thereof
06/20/2006US7064210 Light resistant colorant and composition containing the same
06/20/2006US7064208 Substantially pure cilostazol and processes for making same
06/20/2006US7064207 Androgen receptor antagonists
06/20/2006US7064201 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
06/20/2006US7064144 Imidazole derivatives as adenosine deaminase inhibitors
06/20/2006US7064142 Imidazonline compounds
06/20/2006US7064137 Analgesics; anxiolytic agents; gastrointestinal disorders
06/20/2006US7064136 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents
06/20/2006US7064135 Antihistamines; anticholesterol agents; cardiovascular disorders; antidiabetic agents; anticancer agents
06/20/2006US7064134 4-piperidinyl-substituted, e.g., 4-(2-methyl-4-piperidin-1-yl-quinolin-7-ylmethoxy)-benzonitrile; treating eating disorders and obesity
06/20/2006US7064128 Preferentially substituted calcium channel blockers
06/20/2006US7064118 Cholinergic ligands of the nicotinic acetyl choline receptors; modulators; nervous system disordes, analgesics; smooth muscle contraction; antiinflammatory agents; drug abuse, including smoking; Alzheimer's disease; Parkinson's disease; cognition
06/15/2006WO2006063293A2 THIOUREAS AS FACTOR Xa INHIBITORS
06/15/2006WO2006063113A2 Ureas as factor xa inhibitors
06/15/2006WO2006062978A1 Method for preparing n-phenylpyrazole-1-carboxamides
06/15/2006WO2006062478A1 Novel treatment of gastrointestinal disorders
06/15/2006WO2006062093A1 Novel anthranilic acid derivative or salt thereof
06/15/2006WO2006062069A1 REMEDY FOR PRURITUS COMPRISING p38MAP KINASE AS THE ACTIVE INGREDIENT
06/15/2006WO2006062063A1 Piperidine derivative and process for producing the same
06/15/2006WO2006062062A1 Organic compound, charge-transporting material, and organic electroluminescent element
06/15/2006WO2006061706A1 Tetrazolyl-methylene amino acid derivatives
06/15/2006WO2006061200A1 Anthranilamide derivatives as insecticides
06/15/2006WO2006061147A1 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof
06/15/2006WO2006061116A1 Pyrazine dicarboxamides and the use thereof
06/15/2006WO2006041636A3 Amino substituted aryloxybenzylpiperidine derivatives
06/15/2006WO2006026135A3 Substituted biaryl piperazinyl-pyridine analogues
06/15/2006WO2006015860A3 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor
06/15/2006WO2006003494A3 Piperidine derivatives and their use as insecticides, acaricides, molluscicides or nematicides
06/15/2006WO2006002434A3 Novel indazole carboxamides and their use
06/15/2006WO2005097112A3 Ion channel modulators
06/15/2006WO2005058843A8 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
06/15/2006WO2005056535A8 1,2,3-triazole amide derivatives as inhibitors of cytokine production
06/15/2006US20060128965 chemical intermediates to insecticides and anticoagulant inhibitors of factor Xa having a 1-halophenyl-3-trifluoromethylpyrazole moeity; 1-(1-chloro-2-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid
06/15/2006US20060128963 Piperidine derivatives as melanocortin-4 receptor agonists
06/15/2006US20060128962 Preparation of quinoline-substituted carbonate and carbamate derivatives
06/15/2006US20060128961 Process for the production of meso-substituted cyanine dyes
06/15/2006US20060128957 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
06/15/2006US20060128903 Process for the controlled increase in the molecular weight of polyethylenes
06/15/2006US20060128811 Hydroxamic acid- and N-formyl hydroxylamine hydrazide derivatives; veterinary medicine
06/15/2006US20060128783 Tyrosine kinase inhibitors
06/15/2006US20060128767 Methods of preparing sulfinamides and sulfoxides
06/15/2006US20060128761 Novel triazole compounds as transforming growth factor (TGF) inhibitors
06/15/2006US20060128758 4-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents
06/15/2006US20060128757 Pyridine derivatives useful as cyclooxygenase inhibitor
06/15/2006US20060128756 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
06/15/2006US20060128755 3'-trifluoromethyl-3,4,5,6-tetrahydro-2H-[1,2']-bipyridinyl-4-carboxylic acid (4-isopropylphenyl)amide; antiinflammatory and analgesic
06/15/2006US20060128750 Targeting chemokine receptors and interfere with the binding of the natural ligand thereto; antagonists or agonists; protecting target cells from HIV infection; treating HIV or FIV infected patients
06/15/2006US20060128747 To treat Gram-positive bacterial infections; antibacterial and/or antifungal properties; Preferably drug-resistant strains of bacteria
06/15/2006US20060128737 Androgen receptor agonists
06/15/2006US20060128734 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea;
06/15/2006US20060128722 Indoles useful in the treatment of androgen-receptor related diseases
06/15/2006US20060128717 Therapeutic agents useful for treating pain
06/15/2006US20060128702 Heterocyclic and bicyclic compounds, compositions and methods
06/15/2006US20060128695 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
06/15/2006US20060128692 Non nucleoside reverse transcriptase inhibitors
06/15/2006US20060128687 Lactam glycogen phosphorylase inhibitors and method of use
06/15/2006US20060128686 Preparation of pyridonecarboxylic acid antibacterials
06/15/2006US20060128685 Pyrazole derivative
06/15/2006US20060128684 Anthranilic acid amide derivatives and their pharmaceutical use
06/15/2006US20060128674 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
06/15/2006US20060128669 3-(4-Fluorobenzyl)-8-hydroxy-quinoline-5,7-dicarboxylic acid 7-methylester; against Human T Cell leukemia virus, Feline and Simian immunodeficiency viruses, AIDS and related clinical symptoms
06/15/2006US20060128635 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
06/15/2006US20060128634 Alpha, alpha-disubstituted benzylglycine derivatives as HIV protease inhibitors
06/15/2006US20060128632 Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap)
06/15/2006US20060127914 Nicotinic acetylcholine receptor
06/15/2006US20060127404 Hinge core mimetibodies, compositions, methods and uses
06/15/2006CA2594102A1 Pyrazine dicarboxamides and the use thereof
06/15/2006CA2589718A1 Tetrazolyl-methylene amino acid derivatives
06/15/2006CA2588633A1 Novel anthranilic acid derivative or salt thereof
06/15/2006CA2588148A1 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof
06/15/2006CA2587936A1 Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites
06/15/2006CA2587749A1 Piperidine derivative and process for producing the same
06/14/2006EP1669069A1 Compounds effecting glukokinase
06/14/2006EP1669068A1 Compounds effecting Glucokinase
06/14/2006EP1668006A1 Quinazoline derivatives as antiproliferative agents
06/14/2006EP1668000A1 Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists
06/14/2006EP1667998A2 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease
06/14/2006EP1667997A1 Pyrimidine and pyridine derivatives useful as hmg-coa reductase inhibitors and method of preparation thereof
06/14/2006EP1667996A1 Quinazoline derivatives
06/14/2006EP1667995A1 Benzimidazole acetonitriles
06/14/2006EP1667993A1 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
06/14/2006EP1667992A1 Quinazoline derivatives
06/14/2006EP1667991A1 Quinazoline derivatives as tyrosine kinase inhibitors
06/14/2006EP1667990A2 New compounds
06/14/2006EP1667989A1 Substituted isoquinolinones
06/14/2006EP1667981A1 Isoquinoline potassium channel inhibitors
06/14/2006EP1667980A1 1,4-disubstituted isoquinoline derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
06/14/2006EP1667979A2 Isoquinoline potassium channel inhibitors
06/14/2006EP1667978A2 Isoquinolinone potassium channel inhibitors
06/14/2006EP1667977A1 Isoquinolinone potassium channel inhibitors
06/14/2006EP1667976A1 Isoquinolinone potassium channel inhibitors